Eagle's Eye View: Your Weekly CV Update From ACC.org

This week's View summarizes two recent articles about clinical trials studying the treatment of stroke: TARDIS (Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke) and DAWN (DWI or CTP Assessment With Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention With Trevo).

This week's View summarizes two recent articles from the Journal of the American College of Cardiology. One compares the guidance on primary prevention with statins in the elderly from five major North American and European guidelines, and the other introduces experiences with new transcatheter mitral valve replacement.

This week's View offers a deep dive into the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction.

This week's View discusses three articles on anticoagulation: one about how apixaban compares with other oral anticoagulants for prevention of stroke in patients with atrial fibrillation, one about the use of pharmacomechanical thrombolysis to reduce the risk of the post-thrombotic syndrome in patients with proximal deep-vein thrombosis, and one about how patients fare when oral anticoagulation is resumed following traumatic injury.

This week’s View discusses key points from a two-part journal article about catheter ablation of ventricular tachycardia from the Journal of the American College of Cardiology and an article about measuring high-sensitivity troponin after non-cardiac surgery from the journal Circulation.

This week’s View is part 2 of a two-part discussion of the principles of drug therapy from the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

This week’s View is part 2 of a two-part wrap up from the American Heart Association Scientific Sessions 2017 in Anaheim, California, with Kim Eagle, Peter Block, Deepak Bhatt, and Anthony DeMaria. This podcast reviews the following trials and studies that were presented during days 3 and 4 of the meeting: RE-DUAL PCI, COMPASS, ALLSTAR, and REDUCE LAP-HF.

This week’s View is part 1 of a two-part wrap up from the American Heart Association Scientific Sessions 2017 in Anaheim, California, with Kim Eagle, Deepak Bhatt, and Peter Block. This podcast reviews the following trials and studies that were presented during days 1 and 2 of the meeting: PRESERVE, BRUISE CONTROL-2, TRICS III, CANTOS, and GATEWAY.

This week’s View is part 1 of a two-part discussion of key points to remember from the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

Part 2 of this week’s View comes to you from Deepak Bhatt, Senior Associate Editor for ACC.org, and Peter Block, from Emory University, at Transcatheter Cardiovascular Therapeutics (TCT) 2017 in Denver, Colorado. This podcast reviews the following trials and studies that were presented during days 3 and 4 of the meeting: DAPT-STEMI, TENDYNE, and FAME 2.

Part 1 of this week’s View comes to you from Deepak Bhatt, Senior Associate Editor for ACC.org, and Peter Block, from Emory University, at Transcatheter Cardiovascular Therapeutics (TCT) 2017 in Denver, Colorado. This podcast reviews the following trials and studies that were presented during days 1 and 2 of the meeting: CULPRIT-SHOCK, EXCEL Quality of Life study, and the ABSORB trials.

This week’s View touches on the key points from the 2017 Appropriate Use Criteria for the Management of Severe Aortic Stenosis and the 2017 ACC Expert Consensus Decision Pathway for Mitral Regurgitation and mentions a Patient Case Quiz from the Valvular Heart Disease Clinical Topic Collection on ACC.org.

This week’s View summarizes three articles that are relevant to prevention, specifically the association between gestational diabetes and long-term cardiovascular risk, whether baseline diastolic blood pressure should affect what clinicians think about lowering systolic blood pressure, and how low should the goal be for blood sugar, blood cholesterol, and blood pressure.

In this week’s View, Dr. Eagle highlights an article summarizing several trials presented at the European Society of Cardiology Congress 2017 that was written by experts in interventional cardiology. He also discusses two other recent articles: one about the utility of the Dual Antiplatelet Therapy (DAPT) study score, and one about the pooled events for death and myocardial infarction in two trials studying instantaneous wave-free ratio versus fractional flow reserve.

This week’s View focuses on three recent articles having to do with prevention in and treatment of patients with stable ischemic heart disease. The articles explore the effects of discontinuation of a low-dose aspirin regimen, habitual physical activity, and the drug ivabradine on cardiovascular risk in patients with stable ischemic heart disease.